CA9 and neoplasm: Histopathological markers like necrosis, and biomarkers like hypoxia-inducible factor 1α (HIF-1α), glucose transporter 1 (GLUT-1), and carbonic anhydrase IX (CAIX) to assess protein expression, microRNAs, and novel mRNA signatures, can accurately pinpoint hypoxic regions within tumours.